Education
About Us
Working with TipRanks
Follow Us
Aptorum Group (APM)
:APM
APM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.46 - $7.49
Previous CloseN/A
Volume172.64K
Average Volume (3M)67.03K
Market Cap
$6.58M
Enterprise Value$461.07M
Total Cash (Recent Filing)$2.01M
Total Debt (Recent Filing)$3.28M
Price to Earnings (P/E)49.7
Beta0.82
Next Earnings
Sep 16, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding5,346,823
10 Day Avg. Volume23,808
30 Day Avg. Volume67,035
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.12
Price to Sales (P/S)0.00
P/FCF Ratio-0.16
Enterprise Value/Market Cap70.04
Enterprise Value/Revenue105.79
Enterprise Value/Gross Profit-411.67
Enterprise Value/Ebitda-11.83
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aptorum Group News
PremiumCompany Announcements
Aptorum Group Faces Nasdaq Bid Price Compliance Challenge
PremiumCompany Announcements
Aptorum Group to Issue 1.5 Million Class A Shares
PremiumMarket News
3 Penny Stocks to Watch Now, 01/02/25
PremiumCompany Announcements
Aptorum Group Reports Reduced Net Loss in Mid-2024 Financials
PremiumCompany Announcements
Aptorum Group Announces Shareholder Approval on Key ProposalsPremiumCompany Announcements
Aptorum Group Announces Key Shareholder MeetingOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.05% Mutual Funds
0.26% Other Institutional Investors
99.04% Public Companies and Individual Investors
APM FAQ
What was Aptorum Group’s price range in the past 12 months?
Aptorum Group lowest stock price was $0.46 and its highest was $7.49 in the past 12 months.
What is Aptorum Group’s market cap?
Aptorum Group’s market cap is $6.58M.
When is Aptorum Group’s upcoming earnings report date?
Aptorum Group’s upcoming earnings report date is Sep 16, 2025 which is in 73 days.
How were Aptorum Group’s earnings last quarter?
Aptorum Group released its earnings results on Apr 21, 2025. The company reported -$0.29 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.29.
Is Aptorum Group overvalued?
According to Wall Street analysts Aptorum Group’s price is currently Overvalued.
Does Aptorum Group pay dividends?
Aptorum Group does not currently pay dividends.
What is Aptorum Group’s EPS estimate?
Aptorum Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aptorum Group have?
Aptorum Group has 5,346,823 shares outstanding.
What happened to Aptorum Group’s price movement after its last earnings report?
Aptorum Group reported an EPS of -$0.29 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.614%.
Which hedge fund is a major shareholder of Aptorum Group?
Currently, no hedge funds are holding shares in APM
Company Description
Aptorum Group
Aptorum Group Limited (APM) is a biopharmaceutical company focused on developing and commercializing therapeutic projects to treat unmet medical needs. Based in Hong Kong, Aptorum Group operates across multiple sectors including drug development for infectious diseases, oncology, and other diseases, alongside its healthcare and consumer product businesses. The company emphasizes innovation in its approach to developing small molecule drugs and other therapeutic solutions.
Technical Analysis
Arrowhead Pharmaceuticals
―
BioMarin Pharmaceutical
―
Neurocrine
―
Vertex Pharmaceuticals
―
Sarepta Therapeutics
―